Phase 2 · NCT05951192
TRANSCEND-T2D
CompletedUnverified
Evidence status not confirmed
What this means
The stored verified records do not establish the evidence status.
Registry record
Trial details
- Trial
- TRANSCEND-T2D
- ClinicalTrials.gov ID
- NCT05951192
- Indication
- Type 2 diabetes glycaemic control
- Phase
- Phase 2
- Study type
- Not reported
- Sponsor
- Eli Lilly and Company
- Enrolment
- 540
- Status
- Completed
- Interventions
- Not reported
- Comparator
- Not reported
- Eligible ages
- Not reported
- Locations
- Not reported
- Study start
- Not reported
- Primary completion
- 31 Mar 2026
- Study completion
- Not reported
Verification
- Last verified
- Not yet confirmed
- Source
- Not yet confirmed
- Registry last updated
- Not yet confirmed